These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 18997771)

  • 1. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
    Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
    Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.
    Darden J; Payne LB; Zhao H; Chappell JC
    Angiogenesis; 2019 Feb; 22(1):167-183. PubMed ID: 30238211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
    Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
    Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
    Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
    Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
    Siedlecki J; Wertheimer C; Wolf A; Liegl R; Priglinger C; Priglinger S; Eibl-Lindner K
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):963-972. PubMed ID: 28161830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells.
    Janebodin K; Zeng Y; Buranaphatthana W; Ieronimakis N; Reyes M
    J Dent Res; 2013 Jun; 92(6):524-31. PubMed ID: 23609159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDGF and vessel maturation.
    Hellberg C; Ostman A; Heldin CH
    Recent Results Cancer Res; 2010; 180():103-14. PubMed ID: 20033380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.
    Brudno Y; Ennett-Shepard AB; Chen RR; Aizenberg M; Mooney DJ
    Biomaterials; 2013 Dec; 34(36):9201-9. PubMed ID: 23972477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
    Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
    FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
    Dell S; Peters S; Müther P; Kociok N; Joussen AM
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization.
    Chaoran Z; Zhirong L; Gezhi X
    Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1493-501. PubMed ID: 21574021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
    Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
    Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGS5 expression is a quantitative measure of pericyte coverage of blood vessels.
    Mitchell TS; Bradley J; Robinson GS; Shima DT; Ng YS
    Angiogenesis; 2008; 11(2):141-51. PubMed ID: 18038251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1.
    Eilken HM; Diéguez-Hurtado R; Schmidt I; Nakayama M; Jeong HW; Arf H; Adams S; Ferrara N; Adams RH
    Nat Commun; 2017 Nov; 8(1):1574. PubMed ID: 29146905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining Endothelial Cell-Derived Factors That Promote Pericyte Recruitment and Capillary Network Assembly.
    Kemp SS; Aguera KN; Cha B; Davis GE
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2632-2648. PubMed ID: 32814441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
    Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
    Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.